Top Markets
Coin of the day
Intech Biopharm Corporation Intech Biopharm Corporation

Intech Biopharm Corporation

6461
주식 순위 #22451
Intech Biopharm Corporation is a pharmaceutical company dedicated to the global... Intech Biopharm Corporation is a pharmaceutical company dedicated to the global development and production of generic medications for respiratory conditions. Their portfolio includes innovative drug delivery systems, such as iLEF (inhaled low ethanol formulation), a proprietary metered dose inhaler platform specifically engineered for the treatment of asthma and chronic obstructive pulmonary disease (COPD). Additionally, they offer a dry powder inhaler (DPI) technology, which utilizes blisters and capsules for precise dosage. These therapeutic solutions are marketed under various brand names, including SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011. Established in Taipei, Taiwan, in 2010, the company maintains its headquarters in the city.
주가
$0.49606484
마지막 동기화: 2026-08-21
시가총액
$88.47M
변동 (1일)
-1.58%
변동 (1년)
-22.51%
국가
TW
거래 Intech Biopharm Corporation (6461)

카테고리

Intech Biopharm Corporation (6461)의 EPS
2026 기준 EPS TTM: 0
Intech Biopharm Corporation의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Intech Biopharm Corporation의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS
회사 EPS EPS 차이 국가
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH